Suivre
François Ducray
François Ducray
MD, Department of neuro-oncology, Lyon, France
Adresse e-mail validée de chu-lyon.fr
Titre
Citée par
Citée par
Année
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas
M Sanson, Y Marie, S Paris, A Idbaih, J Laffaire, F Ducray, S El Hallani, ...
J Clin Oncol 27 (25), 4150-4154, 2009
11682009
Primary brain tumours in adults
D Ricard, A Idbaih, F Ducray, M Lahutte, K Hoang-Xuan, JY Delattre
The Lancet 379 (9830), 1984-1996, 2012
7052012
All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
M Labussiere, A Idbaih, XW Wang, Y Marie, B Boisselier, C Falet, S Paris, ...
Neurology 74 (23), 1886-1890, 2010
3182010
Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis
A Viaccoz, V Desestret, F Ducray, G Picard, G Cavillon, V Rogemond, ...
Neurology 82 (7), 556-563, 2014
2592014
Characteristics of H3 K27M-mutant gliomas in adults
D Meyronet, M Esteban-Mader, C Bonnet, MO Joly, E Uro-Coste, ...
Neuro-oncology 19 (8), 1127-1134, 2017
2452017
CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas
R Appay, C Dehais, CA Maurage, A Alentorn, C Carpentier, C Colin, ...
Neuro-oncology 21 (12), 1519-1528, 2019
2282019
Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile
F Ducray, A Idbaih, A de Reyniès, I Bièche, J Thillet, K Mokhtari, S Lair, ...
Molecular cancer 7, 1-17, 2008
1892008
Temozolomide in elderly patients with newly diagnosed glioblastoma and poor performance status: an ANOCEF phase II trial
JG Pérez-Larraya, F Ducray, O Chinot, I Catry-Thomas, L Taillandier, ...
J Clin Oncol 29 (22), 3050-3055, 2011
1852011
Neuroleptic intolerance in patients with anti-NMDAR encephalitis
F Lejuste, L Thomas, G Picard, V Desestret, F Ducray, V Rogemond, ...
Neurology: Neuroimmunology & Neuroinflammation 3 (5), e280, 2016
1742016
A tumor growth inhibition model for low-grade glioma treated with chemotherapy or radiotherapy
B Ribba, G Kaloshi, M Peyre, D Ricard, V Calvez, M Tod, ...
Clinical Cancer Research 18 (18), 5071-5080, 2012
1742012
Characterization of a subtype of autoimmune encephalitis with anti–contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and …
B Joubert, M Saint-Martin, N Noraz, G Picard, V Rogemond, F Ducray, ...
JAMA neurology 73 (9), 1115-1124, 2016
1702016
The molecular landscape of glioma in patients with Neurofibromatosis 1
F D’Angelo, M Ceccarelli, Tala, L Garofano, J Zhang, V Frattini, FP Caruso, ...
Nature medicine 25 (1), 176-187, 2019
1592019
Methylation profiling identifies 2 groups of gliomas according to their tumorigenesis
J Laffaire, S Everhard, A Idbaih, E Criniere, Y Marie, A de Reynies, ...
Neuro-oncology 13 (1), 84-98, 2010
1592010
Quantitative morphological magnetic resonance imaging follow-up of low-grade glioma: a plea for systematic measurement of growth rates
J Pallud, L Taillandier, L Capelle, D Fontaine, M Peyre, F Ducray, ...
Neurosurgery 71 (3), 729-740, 2012
1482012
IDH1 and IDH2 mutations in gliomas.
E De Carli, X Wang, S Puget
The New England journal of medicine 360 (21), 2248; author reply 2249-2248 …, 2009
1442009
Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide …
A Lievre, A Turpin, I Ray-Coquard, K Le Malicot, J Thariat, G Ahle, ...
European Journal of Cancer 141, 62-81, 2020
1402020
Increased frequency of anti-Ma2 encephalitis associated with immune checkpoint inhibitors
A Vogrig, M Fouret, B Joubert, G Picard, V Rogemond, AL Pinto, ...
Neurology: Neuroimmunology & Neuroinflammation 6 (6), e604, 2019
1372019
Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis
A Zekeridou, E Karantoni, A Viaccoz, F Ducray, C Gitiaux, F Villega, ...
Journal of neurology 262, 1859-1866, 2015
1312015
Clinical spectrum of encephalitis associated with antibodies against the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor: case series and review of the literature
B Joubert, P Kerschen, A Zekeridou, V Desestret, V Rogemond, ...
JAMA neurology 72 (10), 1163-1169, 2015
1282015
The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
F Bernard-Arnoux, M Lamure, F Ducray, G Aulagner, J Honnorat, ...
Neuro-oncology 18 (8), 1129-1136, 2016
1162016
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20